Search - tctmd.com

Displaying 821 - 840 of 867

Sort: Relevancy | Date

News Daily News

Door Still Not Shut on CLOSURE I

Yael L. Maxwell

June 15, 2012

Presentation TVT 2012

Targeted Transseptal for Long-Tunnel PFO

Presenter: 74342|Mark Reisman

June 05, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Los CMS Acuerdan Cubrir las TAVR para Usos Aprobados por la FDA

Caitlin E. Cox

May 07, 2012

News Daily News

CMS Agrees to Cover TAVR for FDA-Approved Use

Caitlin E. Cox

May 07, 2012

Presentation TCT Mediterranean 2012

Interventional Approach to ASD/VSD/Paravalvular Leak

Presenter: Manolis Vavuranakis

May 05, 2012

Presentation

Patent Foramen Ovale (PFO) Closure for Cryptogenic Stroke: Neurologists’ Perspective

Presenter: James Grotta

May 02, 2012

Presentation

ASD Closure: Whoa, Wait Till You See a Problem

Presenter: Gurur Biliciler-Denktas

May 02, 2012

Presentation

ASD Closure: Close 'Em if You Find 'Em

Presenter: D. Scott Lim

May 02, 2012

Presentation Fellows 2012

PFO Closure 2012: Indications, Devices, and Outcomes

Presenter: Mark Reisman

April 22, 2012

News Daily News

PFO Closure Helps Exercise-Induced Oxygen Desaturation

Jason Kahn

April 20, 2012

News Daily News

El Cierre del FOP contribuye a la Insaturación de Oxígeno Inducida por el Ejercicio

Jason Kahn

April 20, 2012

Presentation

Provoked Exercise Desaturation in Patent Foramen Ovale and Impact of Percutaneous Closure

Presenter: G.P. Devendra

April 19, 2012

News Daily News

Se Publica el CLOSURE I mientras siguen en Marcha Similares Ensayos del FOV

Caitlin E. Cox

March 15, 2012

News Daily News

CLOSURE I Published as Similar PFO Trials Forge Ahead

Caitlin E. Cox

March 15, 2012

Presentation

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Presenter: Anthony J. Furlan

March 14, 2012

Presentation

CLOSURE I: Cierre o Tratamiento Médico contra el ACV Criptogénico con Foramen Oval Permeable

Presenter: Anthony J. Furlan

March 14, 2012

News Daily News

PFO Closure Can Prevent Recurrent Cerebrovascular Events

Yael L. Maxwell

March 06, 2012

News Daily News

Paper Examines Differences Between Observational, Randomized PFO Closure Studies

L.A. McKeown

March 06, 2012

News Daily News

El Cierre del FOP Puede Prevenir Episodios Cerebrovasculares Recurrentes

Yael L. Maxwell

March 06, 2012

Advertisement

Door Still Not Shut on CLOSURE I

Targeted Transseptal for Long-Tunnel PFO

Watchman Works Just as Well Without Warfarin-Protected Transition

Los CMS Acuerdan Cubrir las TAVR para Usos Aprobados por la FDA

CMS Agrees to Cover TAVR for FDA-Approved Use

Interventional Approach to ASD/VSD/Paravalvular Leak

Patent Foramen Ovale (PFO) Closure for Cryptogenic Stroke: Neurologists’ Perspective

ASD Closure: Whoa, Wait Till You See a Problem

ASD Closure: Close 'Em if You Find 'Em

PFO Closure 2012: Indications, Devices, and Outcomes

PFO Closure Helps Exercise-Induced Oxygen Desaturation

El Cierre del FOP contribuye a la Insaturación de Oxígeno Inducida por el Ejercicio

Provoked Exercise Desaturation in Patent Foramen Ovale and Impact of Percutaneous Closure

Se Publica el CLOSURE I mientras siguen en Marcha Similares Ensayos del FOV

CLOSURE I Published as Similar PFO Trials Forge Ahead

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

CLOSURE I: Cierre o Tratamiento Médico contra el ACV Criptogénico con Foramen Oval Permeable

PFO Closure Can Prevent Recurrent Cerebrovascular Events

Paper Examines Differences Between Observational, Randomized PFO Closure Studies

El Cierre del FOP Puede Prevenir Episodios Cerebrovasculares Recurrentes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content